Suk Ran Yoon Selected Research

Suk Ran Yoon Research Topics

Disease

28	Neoplasms (Cancer) 02/2024 - 07/2003
9	Neoplasm Metastasis (Metastasis) 02/2024 - 02/2008
6	Stomach Neoplasms (Stomach Cancer) 10/2017 - 07/2003
3	Breast Neoplasms (Breast Cancer) 09/2022 - 01/2011
3	Inflammation (Inflammations) 01/2022 - 10/2012
3	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 04/2014
3	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2016 - 08/2007
3	Shock 08/2015 - 11/2012
3	Hypoxia (Hypoxemia) 01/2011 - 02/2008
2	Endometriosis 04/2023 - 10/2014
2	Carcinoma (Carcinomatosis) 12/2022 - 12/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 05/2006
2	Obesity 01/2022 - 12/2017
2	Sepsis (Septicemia) 01/2022 - 01/2019
2	Hematologic Neoplasms (Hematological Malignancy) 07/2020 - 05/2014
2	Thyroid Neoplasms (Thyroid Cancer) 06/2019 - 01/2018
2	Carcinogenesis 01/2017 - 07/2003
2	Leukemia 11/2016 - 05/2014
1	Thrombocytopenia (Thrombopenia) 12/2023
1	Melanoma (Melanoma, Malignant) 12/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2022
1	Septic Shock (Toxic Shock Syndrome) 01/2022
1	Male Infertility (Male Sterility) 06/2021
1	Body Weight (Weight, Body) 06/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Bacterial Infections (Bacterial Infection) 12/2020
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2018
1	Mucositis 01/2018
1	Anaplastic Thyroid Carcinoma 01/2018
1	Insulin Resistance 12/2017

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 12/2023 - 05/2008
8	ThioredoxinsIBA 12/2023 - 04/2010
7	CytokinesIBA 04/2023 - 10/2012
4	Therapeutic UsesIBA 06/2021 - 10/2012
3	LigandsIBA 01/2023 - 01/2018
3	Messenger RNA (mRNA)IBA 01/2020 - 03/2009
3	Small Interfering RNA (siRNA)IBA 04/2014 - 12/2007
2	Phosphotransferases (Kinase)IBA 02/2024 - 07/2020
2	rho Guanine Nucleotide Dissociation Inhibitor alphaIBA 02/2024 - 01/2018
2	Peptides (Polypeptides)IBA 01/2022 - 12/2018
2	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 05/2020 - 01/2018
2	fludarabineIBA 11/2018 - 05/2014
2	Mitogen-Activated Protein KinasesIBA 01/2018 - 07/2003
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2018 - 10/2012
2	Glutathione Reductase (Glutathione-Disulfide Reductase)IBA 01/2017 - 01/2017
2	NF-kappa B (NF-kB)IBA 01/2017 - 02/2008
2	Auranofin (Ridaura)FDA Link 01/2017 - 01/2017
2	Salivary CystatinsIBA 01/2017 - 01/2017
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2015 - 01/2013
2	InflammasomesIBA 08/2015 - 01/2013
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2015 - 01/2013
2	LipopolysaccharidesIBA 08/2015 - 01/2013
2	Granzymes (Granzyme)IBA 02/2015 - 10/2014
2	Interleukin-18 (Interleukin 18)IBA 02/2013 - 02/2008
2	Cholecalciferol (Vitamin D3)FDA Link 04/2010 - 05/2008
1	Polo-Like Kinase 1IBA 02/2024
1	Interleukin-17 (Interleukin 17)IBA 04/2023
1	Actins (F Actin)IBA 01/2023
1	ChemokinesIBA 12/2022
1	Adenosine Triphosphatases (ATPase)IBA 09/2022
1	Ethanol (Ethyl Alcohol)IBA 01/2022
1	fructus aurantii immaturusIBA 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	Local Anti-Infective Agents (Antiseptics)IBA 01/2022
1	AntigensIBA 01/2022
1	Surface Antigens (Surface Antigen)IBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2021
1	Semaphorin-3AIBA 01/2021
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2020
1	Hyaluronic Acid (Hyaluronan)IBA 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 06/2019
1	KynurenineIBA 06/2019
1	p38 Mitogen-Activated Protein KinasesIBA 12/2018
1	Blood Glucose (Blood Sugar)IBA 12/2018
1	ProstaglandinsIBA 01/2018
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2018
1	Death Domain ReceptorsIBA 01/2018
1	Epidermal Growth Factor (EGF)IBA 01/2018
1	Methotrexate (Mexate)FDA LinkGeneric 01/2018
1	Dinoprostone (PGE2)FDA Link 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2018
1	ginsenoside Rg3IBA 12/2017
1	Glucose (Dextrose)FDA LinkGeneric 12/2017
1	Docetaxel (Taxotere)FDA Link 10/2017
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017

Therapy/Procedure

7	Therapeutics 09/2022 - 07/2011
4	Immunotherapy 01/2023 - 08/2007
2	Cell Transplantation 01/2023 - 11/2016
2	Transplantation 11/2016 - 05/2014
1	Traditional Medicine (Folk Remedies) 01/2022
1	Radiotherapy 01/2021
1	Punctures 01/2019
1	Ligation 01/2019
1	Drug Therapy (Chemotherapy) 10/2017